Portal de Periódicos da CAPES

The role of mobile health technologies in allergy care: An EAACI position paper

2019; Wiley; Volume: 75; Issue: 2 Linguagem: Inglês

10.1111/all.13953

1398-9995

Paolo Maria Matricardi, Stephanie Dramburg, Alberto Álvarez‐Perea, Dario Antolín‐Amérigo, Christian Apfelbacher, Marina Atanasković‐Marković, Uwe Berger, Michael S. Blaiss, Simon Blank, Elisa Boni, Matteo Bonini, Jean Bousquet, Knut Brockow, Jeroen Buters, Victòria Cardona, Jean‐Christoph Caubet, Özlem Cavkaytar, Tania Elliott, Ignacio Esteban‐Gorgojo, João Fonseca, James Gardner, Philippe Gevaert, Ileana Maria Ghiordanescu, Peter W. Hellings, Karin Hoffmann‐Sommergruber, Ayşe Füsun Kalpaklıoğlu, F. Marmouz, Á Meijide Calderón, Ralph Mösges, Alla Nakonechna, Markus Ollert, José Oteros, Giovanni Battista Pajno, Cătălina Panaitescu, Daniel Perez-Formigo, Oliver Pfaar, Constantinos Pitsios, Michael Rudenko, Dermot Ryan, S Sánchez-García, Jennifer Shih, Salvatore Tripodi, Lauri‐Ann Van der Poel, Harmieke van Os‐Medendorp, Gilda Varricchi, Jörn Wittmann, Margitta Worm, Ioana Agache,

Food Allergy and Anaphylaxis Research

Abstract Mobile health (mHealth) uses mobile communication devices such as smartphones and tablet computers to support and improve health‐related services, data and information flow, patient self‐management, surveillance, and disease management from the moment of first diagnosis to an optimized treatment. The European Academy of Allergy and Clinical Immunology created a task force to assess the state of the art and future potential of mHealth in allergology. The task force endorsed the “Be He@lthy, Be Mobile” WHO initiative and debated the quality, usability, efficiency, advantages, limitations, and risks of mobile solutions for allergic diseases. The results are summarized in this position paper, analyzing also the regulatory background with regard to the “General Data Protection Regulation” and Medical Directives of the European Community. The task force assessed the design, user engagement, content, potential of inducing behavioral change, credibility/accountability, and privacy policies of mHealth products. The perspectives of healthcare professionals and allergic patients are discussed, underlining the need of thorough investigation for an effective design of mHealth technologies as auxiliary tools to improve quality of care. Within the context of precision medicine, these could facilitate the change in perspective from clinician‐ to patient‐centered care. The current and future potential of mHealth is then examined for specific areas of allergology, including allergic rhinitis, aerobiology, allergen immunotherapy, asthma, dermatological diseases, food allergies, anaphylaxis, insect venom, and drug allergy. The impact of mobile technologies and associated big data sets are outlined. Facts and recommendations for future mHealth initiatives within EAACI are listed.